Nattokinase
Complete medical breakdown of Nattokinase. Understand the pharmacokinetics, clinical indications, and how to safely integrate it into your protocol.
Clinical Summary
Systemic proteolytic enzyme derived from natto. Exhibits strong in-vivo fibrinolytic activity to break down blood clots.
Pharmacokinetics & Bioavailability
When evaluating Nattokinase, the most critical factor is its absorption rate. Currently, the clinical bioavailability score for this specific chemical form is rated at Requires enteric coating.
This high absorption rate ensures that the active compound reaches systemic circulation without causing excessive gastrointestinal distress, provided it is taken correctly.
Optimal Protocol Instructions
- Best Time: Strictly on an empty stomach
- Elemental Dose: 2000 FU (Fibrinolytic Units)
Contraindications & Warnings
Do not take Nattokinase without consulting your physician if you fall into any of the following categories.
Bleeding disorders, concurrent use of anticoagulants (e.g., Warfarin, Eliquis)
Medical Board Pick
We have analyzed the raw material sourcing for Nattokinase to ensure it meets strict clinical standards.
Supports our independent research